![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 26, 19839-19843, June 30, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biochemistry and Microbiology, University of
Victoria, Box 3055, Victoria, British Columbia V8W 3P6, Canada
Received for publication, April 3, 2000, and in revised form, April 18, 2000
Glycosylphosphatidylinositol-anchored proteins
may be concentrated in membrane microdomains (lipid rafts) that are
also enriched in cholesterol and sphingolipids. The glycosyl anchor of
these proteins is a specific, high affinity receptor for the
channel-forming protein aerolysin. We wished to determine if the
presence of rafts promotes the activity of aerolysin. Treatment of T
lymphocytes with methyl- The possibility that lateral phase separations of specific bilayer
components might lead to the occurrence of microdomains in cell
membranes has received a great deal of recent attention (1-4). These
"lipid rafts" are largely defined by their resistance to extraction
with nonionic detergents (5-7). They are enriched in sphingolipids and
cholesterol as well as in a number of membrane proteins, including
several signal-transducing molecules and glycosylphosphatidylinositol (GPI)1-anchored proteins
(7-11). Some members of this latter group of proteins are themselves
involved in cell signaling, while some are enzymes and others have less
well defined functions (12-16).
The channel-forming protein toxin aerolysin and its inactive precursor
proaerolysin have the unique ability to bind specifically and with high
affinity to GPI-anchored proteins on the surfaces of target cells
(17-20). Once bound, proaerolysin may be converted to aerolysin by
surface proteases (21). Bound aerolysin then forms heptameric oligomers
that can insert into the plasma membrane, producing discrete channels
(22). Because binding effectively concentrates the toxin on the cell
surface, promoting oligomerization, cells that display GPI-anchored
proteins are far more sensitive to aerolysin than those that do not
(23, 24). Thus, normal T lymphocytes, which contain several
GPI-anchored proteins that bind aerolysin, including Thy-1, are killed
by 1-h exposure to 10 Recently, it has been proposed that lipid rafts promote channel
formation by aerolysin because the increased density of GPI-anchored proteins therein leads to higher toxin concentrations than elsewhere on
the cell surface, thereby, it was argued, increasing the rate of
oligomerization (25). However, only circumstantial evidence was
presented to support the proposal. It was shown that aerolysin comigrates with the Triton X-100-insoluble fraction upon density gradient centrifugation, which is consistent with the fact that GPI-anchored proteins also tend to migrate there, and with our observation that aerolysin binds these proteins with high affinity (17-20). It was also shown that treating cells with a
cholesterol-lowering agent, which is known to lower the amount of
GPI-anchored protein that is detergent-insoluble, also lowered the
amount of detergent-insoluble aerolysin (25). Surprisingly, however, no
comparison was made of the rate of channel formation by the toxin in
the normal and treated cells.
Although it is possible that the concentration of GPI-anchored proteins
in rafts might promote oligomerization of aerolysin, rafts could
conceivably have the opposite effect. These regions are thought to be
enriched in saturated lipids, so that the lateral mobility of
GPI-anchored proteins may actually be lower when they are in rafts than
when they are in the bulk of the membrane (2, 3). Restricted motion of
bound aerolysin would tend to lower oligomerization rates. In any case,
whether or not aerolysin binding to raft-associated GPI-anchored
proteins does affect the kinetics of oligomerization of the toxin, it
seems unlikely that there would be a significant change in the overall
rate of channel formation. This is because binding rather than
oligomerization is the rate-limiting step in channel formation,
especially at low toxin concentrations (26), so that any influence of
lipid rafts on oligomerization would probably be masked.
In the present study, we looked for direct evidence of an effect of
lipid rafts on channel formation by aerolysin. Cell sensitivity to the
toxin was compared before and after treatment with
methyl- Materials--
Liver phosphatidylcholine (PC) and
phosphatidylethanolamine (PE) and brain sphingomyelin (SM) were
obtained from Avanti Polar Lipids. Cholesterol and a crude preparation
of human placental alkaline phosphatase were purchased from Sigma.
Proaerolysin and the inactive variant Y221G were purified as described
previously. The purified variant was labeled with the fluorescent probe
Alexa 488 (Molecular Probes, Inc., Eugene, OR), using a procedure
provided by the manufacturer.
Cell Culture--
The murine lymphocyte cell line EL4 was
generously provided by Dr. R. Hyman (Salk Institute). Cells were grown
in Dulbecco's modified Eagle's high glucose medium (DMEM)
supplemented with bovine fetal clone I serum (10%, v/v), streptomycin
(100 µg/ml), and penicillin (100 units/ml) with 5% CO2
at 37 °C.
Cholesterol Extraction with Methyl- Measurement of Detergent-insoluble Material--
Lymphocytes (1 ml of 2 × 107 cells/ml in DMEM, 0.5% bovine serum
albumin) were incubated with 10
The detergent solubility of lymphocyte Thy-1 was determined by simply
measuring pelleting after detergent extraction (8). Cells were lysed by
exposure to 1% (w/v) Triton X-100 in PBS with protease inhibitors for
15 min on ice as above. This was followed by centrifugation in a
TA100.2 rotor (Beckman) at 75,000 rpm at 4 °C for 30 min. Protein
was precipitated from the supernatant and the resuspended pellet with
trichloroacetic acid (10%, w/v), and Thy-1 was detected by sandwich
Western blotting.
The detergent insolubility of PLAP incorporated into liposomes was also
measured by centrifugation. Liposomes (100 nmol of lipid) were pelleted
at 75,000 rpm at 4 °C for 20 min in a TA100.2 rotor, and the pellet
was resuspended in 450 µl of 0.1% Triton X-100 in 20 mM
HEPES, 0.15 M NaCl, pH 7.4, and extracted on ice for 15 min. After centrifuging at 75,000 rpm at 4 °C for 30 min, the enzyme
activity was measured in the supernatant and in the pellet resuspended
in the same buffer.
Cell Viability Assay--
Lymphocytes at 106
cells/ml, treated with or without 10 mM
methyl- Measurement of Aerolysin-induced Hemolysis--
Human
erythrocytes were treated with 3.5 mM
methyl-
The aerolysin concentration dependence of rat erythrocyte hemolysis was
determined as described previously (28).
Flow Cytometry--
Control cells and cells that had been
treated with methyl- PLAP Purification--
Twenty-five mg of human PLAP were
dissolved in 50 ml of 1% Triton X-114 in PBS containing 1 mM phenylmethylsulfonyl fluoride by incubating for 20 min
on ice. The extract was separated into detergent-rich and aqueous
phases by warming the sample to 37 °C for 10 min and then
centrifuging in a JA17 rotor (Beckman) for 10 min at 10,000 rpm and
23 °C. The detergent-rich phase was cooled and diluted back to 1%
Triton X-114 by adding cold 20 mM HEPES, pH 7.4. Following
warming and centrifuging to separate the phases once more, protein was
precipitated from the detergent-rich phase by adding 5 volumes of
acetone at Liposome Preparation--
Lipid films containing 12 µmol of
total lipid in the proportions 5 PC:3 PE:3 CH, 3 PC:3 PE:3 CH:2 SM, 4 PC:3 PE:3 CH, and 3 PC:3 PE:3 CH:1 SM, were dried under nitrogen. Dried
films were desiccated overnight and then each rehydrated in 2 ml of 20 mM HEPES, 0.15 M NaCl, 100 mM
carboxyfluorescein, pH 7.4. Liposomes containing sphingomyelin were
rehydrated at 45 °C, while the others were rehydrated at room
temperature. Liposomes were rapidly frozen ( Reconstitution of PLAP into Liposomes--
To determine optimum
octyl glucoside concentrations for incorporation of GPI-anchored
proteins into liposomes, a published method was used (31). The
turbidity of liposomes at 450 nm was monitored while increasing the
concentration of octyl glucoside until the absorbance at 450 nm began
to drop. This detergent concentration (20 mM for 4 PC:3
PE:3 CH, 21 mM for 3 PC:3 PE:3 CH:1 SM, 23 mM for 5 PC:3 PE:3 CH, and 30 mM for 3 PC:3 PE:3 CH:2 SM
liposomes) was chosen for GPI-anchored protein incorporation. 9.5 µg
of PLAP was incubated with 500 µl of 1.3 mM lipid. This
mixture was dialyzed overnight against 20 mM HEPES, 0.15 M NaCl pH7.4 at 4 °C (5 PC:3 PE:3 CH and 4 PC:3 PE:3 CH
liposomes), or 22 °C (sphingomyelin-containing liposomes) to remove
detergent and free carboxyfluorescein. Liposomes were then passed over
a Sephacryl S-300 column (23 ml) in 20 mM HEPES, 0.15 M NaCl, to remove unincorporated PLAP and free dye. Phosphorous assays were performed on liposomes collected off of the column.
Liposome Release Assay--
Carboxyfluorescein release was
measured at 37 °C using a Photon Technology spectrofluorimeter. The
excitation wavelength was set at 490 nm, and the emission wavelength
was set at 520 nm. A 5-nm slit width was used for both monochromators.
Aliquots of liposome preparations (0.26 nmol of lipid) were added to 3 ml of 20 mM HEPES, 0.15 M NaCl, pH 7.4. Activated aerolysin was added to a final concentration of 36 nM at 1 min.
Detection of Proteins by Sandwich Western Blotting--
Samples
were separated by SDS-polyacrylamide gel electrophoresis (32) and
blotted. Blots were probed with proaerolysin, followed by polyclonal
anti-aerolysin and anti-rabbit horseradish peroxidase according to our
published procedure (18). They were then developed by enhanced
chemiluminescence (Amersham Pharmacia Biotech).
Some Aerolysin Is Recovered in a Detergent-insoluble Cell
Fraction--
One of the few easily measured properties of lipid rafts
is their insolubility in some nonionic detergents (5, 7). The raft
lipids and proteins are thought to remain associated in Triton X-100,
and the insoluble complexes can be separated from other cell components
by flotation in sucrose density gradients (5). Since proaerolysin binds
very tightly with GPI-anchored proteins, which partially associate with
the insoluble complexes, some proaerolysin should be found in the
floating fraction after extraction of cells that have been pretreated
with the protein. Such an association was first reported using baby
hamster kidney cells and presented as evidence that rafts favor channel
formation by aerolysin (25). The results in Fig.
1A show that detergent
extraction of EL4 cells pretreated with proaerolysin also led to a
detergent-insoluble fraction, corresponding to rafts, that contained
some of the protoxin. Not all of the protein was recovered with the
floating fraction. Some remained at the bottom of the centrifuge tube,
indicating that it was extracted with detergent and therefore not
raft-associated. A similar distribution of the GPI-anchored protein
Thy-1 was observed (data not shown). This is consistent with the
generally held view that only a fraction of the plasma membrane's
GPI-anchored proteins are localized in rafts at any given time. It was
not possible to make a direct comparison of our results with those
obtained with baby hamster kidney cells, since in that study gradient
fractions were normalized to constant total protein, thereby heavily
weighting the amount of aerolysin apparently associated with the
floating fraction in the SDS-polyacrylamide gels (25).
The fact that detergent extraction of cells that had been incubated
with aerolysin resulted in the recovery of some of the toxin in a
detergent-insoluble fraction is not necessarily evidence that there is
a real and physiologically significant association of the toxin with
rafts in situ. Thus, when aerolysin was added after the
cells had been disrupted with Triton X-100, the amount recovered in the
low density detergent-insoluble fraction did not differ very much from
the amount recovered in this fraction when the cells had been
preincubated with the toxin before extraction (Fig. 1, compare
A and B).
Raft Depletion by Cholesterol Extraction Does Not Affect Channel
Formation in Lymphocytes--
There is considerable evidence that the
detergent-insoluble fraction, or lipid rafts, can be greatly reduced by
lowering the cholesterol content of the membrane. This can be
accomplished by treating cells with the cholesterol-sequestering agent
methyl- Cholesterol Depletion Does Not Decrease the Sensitivity of
Erythrocytes to Aerolysin--
We also studied the effect of
cholesterol depletion on the sensitivity of human erythrocytes.
Erythrocytes are lysed by aerolysin at concentrations similar to those
that kill EL4 cells (Fig. 3), although they contain different
aerolysin-binding GPI-anchored proteins. This too is not surprising,
since aerolysin binds to the anchor, which has a constant core
structure from cell to cell and species to species. Treatment with 3.5 mM methyl- Rafts in Liposomes Do Not Promote Channel Formation--
The above
results lend no support to the idea that lipid rafts have an important
role to play in channel formation by aerolysin. However, although it
seemed unlikely that the erythrocytes used to obtain the data in Fig. 4
could contain any significant raft population after extraction of 90%
of their cholesterol, we could not exclude the possibility that a small
raft population remained. In order to compare membranes totally lacking
rafts with membranes that contain a detergent-soluble fraction, we
decided to use large unilamellar vesicles containing a GPI-anchored
protein that acts as an aerolysin receptor. We have previously shown
that Thy-1 is an excellent receptor for aerolysin when it is
incorporated into liposomes; however, for the present study we wished
to use a protein that could be more easily quantitated, so we first
determined if GPI-anchored placental alkaline phosphatase could
substitute for Thy-1. The results in Fig.
5A show that the addition of
36 nM aerolysin to liposomes containing incorporated PLAP
resulted in rapid dye release, whereas liposomes without PLAP were not affected by this concentration of the toxin. We obtained a very similar
pattern with liposomes containing incorporated Thy-1 (18).
Having shown that PLAP is an aerolysin receptor, we then incorporated
the enzyme into liposomes of different lipid compositions. Most of the
PLAP in the 3:3:3:2 (PC:PE:CH:SM) vesicles was detergent-insoluble, evidence for the presence of rafts, whereas all of the enzyme in
liposomes lacking SM was soluble in Triton X-100. Vesicles made with
half as much SM had approximately half as much detergent-insoluble PLAP
(data not shown). The ability to prepare liposomes with and without
rafts allowed us to determine directly whether or not these lipid
structures have any pronounced effect on aerolysin sensitivity. The
rates of channel formation by aerolysin were next compared in liposomes
lacking raft-associated PLAP or containing moderate (Fig.
5A) or large amounts (Fig. 5B) of the
detergent-insoluble enzyme. It may be seen that there were only minor
differences in the rate of dye release regardless of the liposome
composition. Release from the liposomes containing large amounts of
raft PLAP was actually somewhat slower than from the corresponding
liposomes lacking sphingomyelin (Fig. 5B). The two liposome
populations contained very similar proportions of PLAP to lipid,
although the SM-containing population was somewhat smaller. Comparable results were obtained when lower concentrations of aerolysin were used
(data not shown).
Although the results in this paper cast no direct light on the
existence or significance of lipid rafts in cell membranes, they
clearly show that if these structures exist, they have little or no
influence on the rate of channel formation by aerolysin, either in
whole cells or in liposomes. The result is not surprising for two
reasons. First, even if rafts did alter the rate of aerolysin oligomerization, we would not expect to see an effect on cells unless
oligomerization becomes the rate-limiting step in channel formation.
Normally, binding is rate-limiting, and there is no reason to believe
that GPI-anchored proteins clustered in rafts would bind the toxin any
better than when they are distributed on the cell surface. In fact, the
results in Fig. 2 show that binding is not affected by raft disruption.
Second, it is not intuitively obvious that, even if oligomerization
were the rate-limiting step in channel formation, it would occur more
quickly if the receptors were clustered in rafts. Membrane GPI-anchored
proteins could be less mobile when they occur in these regions, because of the increased levels of relatively saturated fatty acids found there
(7). The reduced mobility could lower the rate of oligomerization of
the bound toxin. In any case, GPI-anchored proteins are also located in
the bulk of the lipid bilayer, where they are apparently very mobile,
some have speculated even more mobile than transmembrane proteins (3,
14). They appear to simply pause in rafts as they move about the cell
surface; at any given time, only a fraction is thought to be localized
in rafts (3, 33).
The results we obtained with erythrocytes extracted with
methyl- In conclusion, the unusual ability of aerolysin to bind to GPI-anchored
proteins may provide a new tool to study the chemistry and biology of
lipid rafts, but there is no reason to believe that these structures
are important in the process of channel formation by the toxin.
We thank Félix Goñi and Alicia
Alonzo for helpful discussions. The technical assistance of Ryan Barry
is gratefully acknowledged.
*
This work was supported by grants from the Natural Sciences
and Engineering Research Council of Canada and from the Medical Research Council of Canada.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, April 18, 2000, DOI 10.1074/jbc.M002785200
The abbreviations used are:
GPI, glycosylphosphatidylinositol;
PLAP, placental alkaline phosphatase;
PC, phosphatidylcholine;
PE, phosphatidylethanolamine;
CH, cholesterol;
SM, sphingomyelin;
DMEM, Dulbecco's modified Eagle's high glucose medium;
PBS, phosphate-buffered saline.
Channel Formation by the Glycosylphosphatidylinositol-anchored
Protein Binding Toxin Aerolysin Is Not Promoted by Lipid Rafts*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-cyclodextrin, which destroys lipid rafts by
sequestering cholesterol, had no measurable effect on the sensitivity
of the cells to aerolysin; nor did similar treatment of erythrocytes decrease the rate at which they were lysed by the toxin. We also studied the rate of aerolysin-induced channel formation in liposomes containing glycosylphosphatidylinositol-anchored placental alkaline phosphatase, which we show is a receptor for aerolysin. In liposomes containing sphingolipids as well as glycerophospholipids and
cholesterol, most of the enzyme was Triton X-100-insoluble, indicating
that it was localized in rafts, whereas in liposomes prepared without sphingolipids, all of the enzyme was soluble. Aerolysin was no more
active against liposomes containing rafts than against those that did
not. We conclude that lipid rafts do not promote channel formation by aerolysin.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
10 M
aerolysin or proaerolysin, whereas T lymphocytes that lack GPI-anchored
proteins because they are unable to synthesize the anchor are
approximately 104-fold less sensitive. Similarly, we have
shown that channel formation in artificial lipid bilayers occurs at far
lower aerolysin concentrations if the bilayers contain incorporated
GPI-anchored proteins, such as Thy-1 from brain or lymphocytes, or the
erythrocyte aerolysin receptor, a novel aerolysin-binding GPI-anchored
protein purified from erythrocytes (17, 18).
-cyclodextrin, which abolishes lipid rafts by reducing plasma
membrane cholesterol levels (27). We found that the sensitivity of a T
cell line was unaffected by cholesterol extraction; nor was the
sensitivity of erythrocytes decreased by cholesterol removal. We also
studied liposomes containing incorporated GPI-anchored placental
alkaline phosphatase (PLAP), which we show acts as an aerolysin
receptor. Liposomes containing PLAP associated with rafts were no more
sensitive to aerolysin than liposomes that were raft-free.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-cyclodextrin--
EL4
cells at 2 × 106 cells/ml were washed twice in neat
DMEM and then incubated with or without 10 mM
methyl-
-cyclodextrin in DMEM for 30 min at 37 °C, rotating end
over end. Following extraction, half of the cells were washed twice in
DMEM and used in the cytotoxicity assay and for flow cytometry; the
other half were washed twice in PBS, and then a cholesterol
determination (Cholesterol 20; Sigma) was performed on them.
8
M Y221G proaerolysin on ice for 1 h. We used the
proaerolysin variant here because it can bind as well as native
proaerolysin but does not cause cell death, since it cannot form
functional channels. Following incubation, the cells were washed twice
in PBS and then extracted with 500 µl of 25 mM Tris, pH
7.5, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100
(w/v), containing a protease inhibitor mixture (1 mM
phenylmethylsulfonyl fluoride, 2 µg/ml aprotinin, 2.2 µg/ml
leupeptin, and 1 µg/ml pepstatin) for 30 min on ice. In some
experiments, the detergent extraction step was carried out first; then
10
8 M Y221G was added to the
cells, and the mixture was incubated for 15 min at 4 °C. Mixtures
were adjusted to 1.5 M sucrose and overlaid with 8 ml of
1.2 M sucrose, 10 mM Tris, pH 7.4, followed by
2.5 ml of 0.15 M sucrose, 10 mM Tris, pH 7.4. The samples were then centrifuged in an SW41 rotor at 38,000 rpm for
18 h at 4 °C. Fractions of 1 ml were collected, and sample
buffer was added for SDS-PAGE. Material at the bottoms of the
centrifuge tubes was suspended directly in sample buffer.
-cyclodextrin as above, were incubated with a range of
proaerolysin concentrations for 1 h at 37 °C under 5%
CO2. Both
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium and phenazine methosulfate were then added to final concentrations of
333 and 7.66 µg/ml, respectively. The samples were incubated at
37 °C with 5% CO2 for 4 h, after which the
A490 was measured as described previously
(23).
-cyclodextrin or PBS alone and then washed with PBS.
Activated aerolysin was added to a final concentration of 5 nM in stirred cuvettes containing 1.5 ml of 0.8% (v/v)
washed cells in PBS. The rate of hemolysis was monitored by measuring
the decrease in optical density of the erythrocyte suspensions at 600 nM and 37 °C as a function of time. Readings were made
using a Varian Cary I recording spectrophotometer as described
previously (24).
-cyclodextrin for 30 min at 37 °C were
exposed to 10
8 M Alexa
488-labeled Y221G proaerolysin for 30 min on ice. They were then washed
twice with PBS and analyzed by flow cytometry.
20 °C and incubating on ice for 30 min and then
centrifuging at 5000 rpm for 30 min at 0 °C in a JA17 rotor. The
acetone was decanted, and the pellet was dried for 2 h under
vacuum. The dried pellet was resuspended in 20 mM HEPES, pH
7.4, containing 1% octyl glucoside, and applied to a DEAE column
equilibrated in the same buffer. The column was eluted with a salt
gradient of 0-0.5 M NaCl in 20 mM HEPES, pH 7.4, 1% octyl glucoside. Enzyme activity, which was assayed using a
standard alkaline phosphatase assay (Sigma), appeared at approximately 0.18 M salt. Silver staining after SDS-polyacrylamide gel
electrophoresis produced a single band accounting for more than 95% of
applied material. The purified protein had a specific activity of
approximately 400 units/mg, slightly less than the specific activity
reported previously for purified alkaline phosphatase lacking the GPI
anchor (29).
70 °C acetone bath)
and thawed (45 °C water bath) six times. After freeze thawing,
liposomes were passed through a 0.4-µm polycarbonate filter
(Nucleopore) six times, using a Lipex Biomembrane extruder. The
sphingomyelin liposomes were extruded at 45 °C, and the others were
extruded at room temperature. Lipid phosphorous was measured according
to a published procedure (30). Vesicle size was determined using a
Nicomp Submicron particle sizer.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (26K):
[in a new window]
Fig. 1.
Aerolysin is partly recovered in a
detergent-insoluble fraction when added before or after cell disruption
with Triton X-100. A, EL4 cells were incubated with
10
8 M Y221G and then extracted
with Triton X-100 as described under "Experimental Procedures."
B, cells were extracted with detergent and then
10
8 M Y221G aerolysin was
added.
-cyclodextrin (27). Extraction of EL4 cells with 10 mM methyl-
-cyclodextrin for 30 min led to a 45% decline
in cholesterol levels and a striking change in the amount of Thy-1
detected in the detergent-insoluble fraction (data not shown), evidence
that rafts had been greatly reduced. Flow cytometric analysis of the
treated and control cells using a fluorescently labeled toxin indicated
that cholesterol extraction had little or no effect on aerolysin
binding (Fig. 2). This was not
surprising, since there is no reason to believe that there should be
any difference in the binding of the protein to GPI-anchored proteins
whether they are located in rafts or distributed on the rest of the
membrane surface. More importantly, the results in Fig.
3 show that the depleted cells,
containing considerably less cholesterol and detergent-insoluble
GPI-anchored protein, were no less sensitive to the toxin than the
untreated cells.

View larger version (13K):
[in a new window]
Fig. 2.
Raft reduction has no effect on the binding
of aerolysin to lymphocytes. Flow cytometry analysis of binding of
fluorescently labeled aerolysin to untreated T lymphocytes
(solid line) and lymphocytes treated with 10 mM methyl-
-cyclodextrin (dotted
line).

View larger version (15K):
[in a new window]
Fig. 3.
Raft reduction does not affect the
sensitivity of T lymphocytes to aerolysin. Cell viability was
determined before (
) and after (
) raft disruption by
methyl-
-cyclodextrin. Also shown is the sensitivity of untreated rat
erythrocytes to aerolysin (
). The percentage of cell lysis of
erythrocytes was determined spectrophotometrically as described
previously (28). Lymphocyte cell viability was measured as described
under "Experimental Procedures."
-cyclodextrin for 60 min removed 90% of the
erythrocyte cholesterol, a higher percentage than is removed from other
cell types, presumably because erythrocyte cholesterol is entirely
associated with the plasma membrane. Remarkably, the nearly complete
extraction of the steroid from the cells did not lower the rate at
which they were lysed by aerolysin (Fig.
4), despite the fact that the amount of
raft-associated GPI-anchored protein, if any, must have been very
small.

View larger version (13K):
[in a new window]
Fig. 4.
Erythrocytes do not become less sensitive to
aerolysin following cholesterol extraction. Kinetic analysis of
aerolysin-induced hemolysis of control erythrocytes (solid
line) and erythrocytes treated with 3.5 mM
methyl-
-cyclodextrin (hatched line) is
shown.

View larger version (18K):
[in a new window]
Fig. 5.
Liposomes containing PLAP in rafts are not
more sensitive to aerolysin than liposomes lacking rafts.
A, the rates of dye release from 3 PC:3 PE:3 CH:1 SM
liposomes (moderate raft-associated PLAP) and 4 PC:3 PE:3 CH liposomes,
lacking rafts, were virtually identical (solid and
dotted lines at the top). The
flat dotted curve at the
bottom was obtained with PLAP-free 3 PC:3 PE:3 CH:1 SM
liposomes. The PLAP liposomes containing sphingomyelin were 216 nm in
diameter, while those lacking sphingomyelin were 157 nm. B,
aerolysin sensitivity of 3 PC:3 PE:3 CH:2 SM (high raft-associated
PLAP; dotted line) and raft-free 5 PC:3 PE:3 CH
liposomes (solid line). Liposomes containing
sphingomyelin were 145 nm in diameter, while those lacking
sphingomyelin were 195 nm in diameter. Both liposome preparations
contained 1 receptor/1850 nm2 of exterior lipid surface.
All liposomes were treated with 36 nM aerolysin at room
temperature as described under "Experimental Procedures." These
results are representative of several experiments. Similar results were
obtained at 37 °C.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-cyclodextrin allow us to comment on the role of cholesterol in channel formation by aerolysin. There has been a recent report that
aerolysin is inhibited when preincubated with cholesterol, which was
taken as evidence that the toxin can interact with the steroid (34).
Earlier we had shown that aerolysin is capable of forming channels in
cholesterol-free liposomes, indicating that it has no absolute
requirement for the steroid (35). Here we found that removing nearly
all of the cholesterol from the cell did not lower the rate of channel
formation. Thus, it would seem that cholesterol plays no significant
role in the action of aerolysin.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed. Tel.: 250-721-7081;
Fax: 250-598-6877; E-mail: tbuckley@uvic.ca.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Brown, D. A.,
and London, E.
(1998)
Annu. Rev. Cell Dev. Biol.
14,
111-136
2.
Brown, D. A.,
and London, E.
(1998)
J. Memb. Biol.
164,
103-114
3.
Jacobson, K.,
and Dietrich, C.
(1999)
Trends Cell Biol.
9,
87-91
4.
Kurzchalia, T. V.,
and Parton, R. G.
(1999)
Curr. Opin. Cell Biol.
11,
424-431
5.
Fra, A. M.,
Williamson, E.,
Simons, K.,
and Parton, R. G.
(1994)
J. Biol. Chem.
269,
30745-30748
6.
Ostermeyer, A.,
Beckrich, B.,
Ivarson, K.,
Grove, K.,
and Brown, D.
(1999)
J. Biol. Chem.
274,
34459-34466
7.
Schroeder, R.,
London, E.,
and Brown, D. A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
12130-12134
8.
Benting, J.,
Rietveld, A.,
Ansorge, I.,
and Simons, K.
(1999)
FEBS
462,
47-50
9.
Friedrichson, T.,
and Kurzchalia, T. V.
(1998)
Nature
394,
802-805
10.
Harder, T.,
and Simons, K.
(1999)
Eur. J. Immunol.
29,
556-562
11.
Varma, R.,
and Mayor, S.
(1998)
Nature
394,
798-801
12.
Brown, D.
(1993)
Curr. Opin. Immun.
5,
349-354
13.
Janes, P. W.,
Ley, S. C.,
and Magee, A. I.
(1999)
J. Cell Biol.
147,
447-461
14.
McConville, M. J.,
and Ferguson, M. A. J.
(1993)
Biochem. J.
294,
305-324
15.
Redman, C. A.,
Thomas-Oates, J. E.,
Ogata, S.,
Ikehara, Y.,
and Ferguson, M. A.
(1994)
Biochem. J.
302,
861-865
16.
Roberts, W. L.,
Kim, B. H.,
and Rosenberry, T. L.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
7817-7821
17.
Cowell, S.,
Wolfgang, A.,
Gruber, H. J.,
Nelson, K. L.,
and Buckley, J. T.
(1997)
Molec. Microbiol.
25,
343-350
18.
Nelson, K. L.,
Raja, S. M.,
and Buckley, J. T.
(1997)
J. Biol. Chem.
272,
12170-12174
19.
Diep, D. B.,
Nelson, K. L.,
Raja, S. M.,
Pleshak, E. N.,
and Buckley, J. T.
(1998)
J. Biol. Chem.
273,
2355-2360
20.
MacKenzie, C. R.,
Hirama, T.,
and Buckley, J. T.
(1999)
J. Biol. Chem.
274,
22604-22609
21.
Abrami, L.,
Fivaz, M.,
Decroly, E.,
Seidah, N. G.,
Jean, F.,
Thomas, G.,
Leppla, S. H.,
Buckley, J. T.,
and van der Goot, F. G.
(1998)
J. Biol. Chem.
273,
32656-32661
22.
van der Goot, F. G.,
Pattus, F.,
Wong, K. R.,
and Buckley, J. T.
(1993)
Biochemistry
32,
2636-2642
23.
Nelson, K. L.,
Brodsky, R. A.,
and Buckley, J. T.
(1999)
Cell. Micro.
1,
69-74
24.
Brodsky, R. A.,
Mukhina, G.,
Nelson, K. L.,
Lawrence, T. S.,
Jones, R. J.,
and Buckley, J. T.
(1999)
Blood
93,
1749-1756
25.
Abrami, L.,
and van der Goot, F. G.
(1999)
J. Cell Biol.
147,
175-184
26.
Garland, W. J.,
and Buckley, J. T.
(1988)
Infect. Immun.
56,
1249-1253
27.
Ilangumaran, S.,
and Hoessli, D. C.
(1998)
Biochem. J.
335,
433-440
28.
Diep, D. B.,
Nelson, K. L.,
Lawrence, T. S.,
Sellman, B.,
Tweten, R. K.,
and Buckley, J. T.
(1999)
Molec. Microbiol.
31,
785-794
29.
Chang, T. C.,
Huang, S. M.,
Huang, T. M.,
and Chang, G. G.
(1992)
Eur. J. Biochem.
209,
241-247
30.
Bartlett, G. R.
(1959)
J. Biol. Chem.
234,
466-468
31.
Nosjean, O.,
and Roux, N.
(1999)
Eur. J. Biochem.
263,
865-870
32.
Neville, D. M.
(1971)
J. Biol. Chem.
246,
6328-6334
33.
Sheets, E. D.,
Lee, G. M.,
Simson, R.,
and Jacobson, K.
(1997)
Biochemistry
36,
12449-12458
34.
Ferguson, M. R,
Xu, X. J.,
Houston, C. W.,
Peterson, J. W.,
Coppenhaver, D. H.,
Popov, V. L.,
and Chopra, A. K.
(1997)
Infect. Immun.
65,
4299-4308
35.
Howard, S. P.,
and Buckley, J. T.
(1982)
Biochemistry
21,
1662-1667
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Mandal, A. Mazumder, P. Das, M. Kundu, and J. Basu Fas-, Caspase 8-, and Caspase 3-dependent Signaling Regulates the Activity of the Aminophospholipid Translocase and Phosphatidylserine Externalization in Human Erythrocytes J. Biol. Chem., November 25, 2005; 280(47): 39460 - 39467. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fukushima, Y. Ikehara, and K. Yamashita Functional Role Played by the Glycosylphosphatidylinositol Anchor Glycan of CD48 in Interleukin-18-induced Interferon-{gamma} Production J. Biol. Chem., May 6, 2005; 280(18): 18056 - 18062. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Giddings, A. E. Johnson, and R. K. Tweten Redefining cholesterol's role in the mechanism of the cholesterol-dependent cytolysins PNAS, September 30, 2003; 100(20): 11315 - 11320. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fujii, T. Nomura, R. Yokoyama, S. Shinoda, and K. Okamoto Studies of the Mechanism of Action of the Aerolysin-Like Hemolysin of Aeromonas sobria in Stimulating T84 Cells To Produce Cyclic AMP Infect. Immun., March 1, 2003; 71(3): 1557 - 1560. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miyata, J. Minami, E. Tamai, O. Matsushita, S. Shimamoto, and A. Okabe Clostridium perfringensepsilon -Toxin Forms a Heptameric Pore within the Detergent-insoluble Microdomains of Madin-Darby Canine Kidney Cells and Rat Synaptosomes J. Biol. Chem., October 11, 2002; 277(42): 39463 - 39468. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Petit, E. Maier, M. Gibert, M. R. Popoff, and R. Benz Clostridium perfringens Epsilon Toxin Induces a Rapid Change of Cell Membrane Permeability to Ions and Forms Channels in Artificial Lipid Bilayers J. Biol. Chem., May 4, 2001; 276(19): 15736 - 15740. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |